TTF-1 and immune checkpoint therapy in non-small cell lung cancer

Transl Lung Cancer Res. 2023 Mar 31;12(3):398-400. doi: 10.21037/tlcr-23-101. Epub 2023 Mar 24.

Authors

Matthew Gumbleton^{1

2}, Eric L Snyder^{2

3}

Affiliations

¹ Division of Oncology, Department of Internal Medicine, University of Utah, Salt Lake City, UT, USA.
² Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.
³ Department of Pathology, University of Utah, Salt Lake City, UT, USA.

No abstract available

Keywords: Thyroid transcription factor-1 (TTF-1); immune checkpoint therapy; non-small cell lung cancer (NSCLC).

Publication types

Editorial
Comment